Sight Sciences Net Worth

Sight Sciences Net Worth Breakdown

  SGHT
The net worth of Sight Sciences is the difference between its total assets and liabilities. Sight Sciences' net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Sight Sciences' assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Sight Sciences' net worth can be used as a measure of its financial health and stability which can help investors to decide if Sight Sciences is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Sight Sciences stock.

Sight Sciences Net Worth Analysis

Sight Sciences' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Sight Sciences' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Sight Sciences' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Sight Sciences' net worth analysis. One common approach is to calculate Sight Sciences' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Sight Sciences' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Sight Sciences' net worth. This approach calculates the present value of Sight Sciences' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Sight Sciences' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Sight Sciences' net worth. This involves comparing Sight Sciences' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Sight Sciences' net worth relative to its peers.
To determine if Sight Sciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Sight Sciences' net worth research are outlined below:
Sight Sciences had very high historical volatility over the last 90 days
Sight Sciences has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 79.87 M. Net Loss for the year was (51.51 M) with profit before overhead, payroll, taxes, and interest of 66.91 M.
Sight Sciences currently holds about 220.1 M in cash with (22.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Sight Sciences has a frail financial position based on the latest SEC disclosures
Roughly 21.0% of the company outstanding shares are owned by corporate insiders
Sight Sciences uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Sight Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Sight Sciences' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
11th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
11th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Follow Sight Sciences' market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 183.03 M.

Project Sight Sciences' profitablity

The company has Profit Margin (PM) of (0.63) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.79) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.79.
When accessing Sight Sciences' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Sight Sciences' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Sight Sciences' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Sight Sciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sight Sciences. Check Sight Sciences' Beneish M Score to see the likelihood of Sight Sciences' management manipulating its earnings.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sight Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sight Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sight Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Badawi David 3 days ago
Disposition of 40000 shares by Badawi David of Sight Sciences at 0.12 subject to Rule 16b-3
 
Badawi David over two weeks ago
Disposition of 5679 shares by Badawi David of Sight Sciences at 4.174 subject to Rule 16b-3
 
Matthew Link over two weeks ago
Disposition of 4889 shares by Matthew Link of Sight Sciences at 4.098 subject to Rule 16b-3
 
Encrantz Staffan over three weeks ago
Acquisition by Encrantz Staffan of 120000 shares of Sight Sciences at 2.53 subject to Rule 16b-3
 
Jeremy Hayden over a month ago
Disposition of 1810 shares by Jeremy Hayden of Sight Sciences at 3.259 subject to Rule 16b-3
 
Matthew Link over a month ago
Acquisition by Matthew Link of 172043 shares of Sight Sciences subject to Rule 16b-3
 
Encrantz Staffan over a month ago
Acquisition by Encrantz Staffan of 21674 shares of Sight Sciences at 4.172 subject to Rule 16b-3
 
Encrantz Staffan over a month ago
Acquisition by Encrantz Staffan of 25230 shares of Sight Sciences at 3.967 subject to Rule 16b-3
 
Encrantz Staffan over a month ago
Acquisition by Encrantz Staffan of 30799 shares of Sight Sciences at 3.878 subject to Rule 16b-3
 
Encrantz Staffan over a month ago
Acquisition by Encrantz Staffan of 42753 shares of Sight Sciences at 3.67 subject to Rule 16b-3
 
Encrantz Staffan over a month ago
Acquisition by Encrantz Staffan of 60128 shares of Sight Sciences at 3.588 subject to Rule 16b-3
 
Encrantz Staffan over a month ago
Acquisition by Encrantz Staffan of 26715 shares of Sight Sciences at 3.516 subject to Rule 16b-3
Sight Sciences time-series forecasting models is one of many Sight Sciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sight Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Sight Sciences Earnings per Share Projection vs Actual

Sight Sciences Corporate Management

Additional Tools for Sight Stock Analysis

When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.